Noninvasive Brain Stimulation Enhances Recovery Potential of Visual Restoration Therapy in Hemianopia Patients: Presented at ANA
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Noninvasive Brain Stimulation Enhances Recovery Potential of Visual Restoration Therapy in Hemianopia Patients: Presented at ANA

By Crina Frincu-Mallos, PhD

BALTIMORE, Md -- October 16, 2009 -- Neurovisual rehabilitation induces a significant improvement in the patients’ field of vision, when added to noninvasive brain stimulation in patients with hemianopia, according to a study presented here October 15 at the American Neurological Association (ANA) 134th Annual Meeting.

“We present here preliminary evidence for efficacy of combining brain stimulation with neurovisual restoration therapy,” said Ela B. Plow, PhD, Department of Neurology, Berenson-Allen Center for Noninvasive Brain Stimulation, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Visual restoration therapy (VRT) trains the so-called transition zone, a region of the affected hemifield that separates the blind zone from the intact area and can improve vision by an average 5 degrees.

However, “critics argue that improvement from VRT does not alter function and is confounded by saccades,” said Dr. Plow. Yet, this “improvement in function cannot be explained by eye movements,” and the neural substrates for improvement “possibly include reorganisation of extravisual cortices,” she added.

In a randomised, controlled, double-blind study, Dr. Plow and her team tested VRT in combination with brain stimulation in patients with hemianopia. They took this concept from stroke motor research, where it was observed that brain stimulation acts synergistically with forced use rehabilitation of an affected limb, attributed to an enhancement of the cortical excitability of the surviving motor networks.

“Since the aim of VRT is forced use of the affected hemifield of vision,” argued Dr. Plow, “its efficacy could be enhanced using visual cortical stimulation.”

The investigators hypothesised that combining VRT with transcranial direct current stimulation (tDCS) of intact and affected visual cortices, over 3 months, would enhance VRT’s efficacy by modulating plastic potential of residual neurons.

Patients were randomly assigned to group 1 (VRT combined with tDCS) or group 2 (VRT combined with sham tDCS) and were trained using an eye-tracker for 30 minutes, twice daily, 3 days per week, for a 3-month period.

Dependent measures included visual field tests, eye tracking, clinical measure of perimetry, functional magnetic resonance imaging (fMRI) during a visual motion task, a functional questionnaire, and subjective blind field drawing.

After 3 months of training, accuracy on visual field test improved by 6.8 % in group 1, compared with only 2.3% in group 2. In addition, the visual field gain in the patients in group 1 was 5.2 degrees, compared with 1.93 degrees in group 2. The functional questionnaire demonstrated gain only on patients in group 1.

The investigators also showed preliminary fMRI data, currently available in 3/7 patients, that confirmed neurovisual rehabilitation following training and showed reorganisation of extravisual areas.

However, “transfer of visual field change from VRT to clinical perimetry is still not clearly evident,” Dr. Plow acknowledged.

In addition to considering methodological refinements, the investigators said that more patients are needed to understand the validity of these preliminary results.

[Presentation title: Neuro-Visual Rehabilitation Combined With Noninvasive Brain Stimulation to Enhance Function in Patients With Hemianopia. Abstract M-113]


E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities